4.2 Article

Relationships Between Performance on the Cogstate Brief Battery, Neurodegeneration, and Aβ Accumulation in Cognitively Normal Older Adults and Adults with MCI

期刊

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY
卷 30, 期 1, 页码 49-58

出版社

OXFORD UNIV PRESS
DOI: 10.1093/arclin/acu068

关键词

beta-amyloid; Hippocampal volume; Episodic memory; Preclinical AD; MCI; Neuropsychological assessment

向作者/读者索取更多资源

We investigated the extent to which decline in memory and working memory in beta-amyloid (A beta) positive non-demented individuals was related to hippocampal atrophy and A beta accumulation over 36 months. Cognitively normal older adults (CN) (n = 178) and adults with mild cognitive impairment (MCI) (n = 49) underwent positron emission tomography neuroimaging, magnetic resonance imaging, and cognitive assessments at baseline, 18- and 36-months. Relative to A beta- CNs, A beta+ CNs and A beta+ MCIs showed greater rates of cognitive decline, A beta accumulation, and hippocampal atrophy. Analysis of interrelationships between these Alzheimer's disease markers in A beta+ CNs and MCIs indicated that rate of A beta accumulation was associated with rate of hippocampal atrophy (beta = -0.05, p = .037), which was in turn associated independently with rate of decline in memory (beta = -0.03, p = .032). This suggests that A beta accumulation precedes any neurodegeneration or clinical symptoms, and that the relationship between A beta and cognitive decline is mediated by hippocampal atrophy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Tau and amyloid biomarkers modify the degree to which cognitive reserve and brain reserve predict cognitive decline

Cathryn McKenzie, Romola S. Bucks, Michael Weinborn, Pierrick Bourgeat, Olivier Salvado, Brandon E. Gavett

Summary: The study found that brain reserve and cognitive reserve can predict slower decline in executive function in older adults. When Alzheimer's disease pathology is low, only brain reserve can attenuate decline. Education is not independently associated with cognitive decline.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2023)

Article Clinical Neurology

Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with A beta-PET, neurodegeneration, and cognition

Pratishtha Chatterjee, Lisa Vermunt, Brian A. Gordon, Steve Pedrini, Lynn Boonkamp, Nicola J. Armstrong, Chengjie Xiong, Abhay K. Singh, Yan Li, Hamid R. Sohrabi, Kevin Taddei, Mark Molloy, Tammie L. S. Benzinger, John C. Morris, Celeste Karch, Sarah Berman, Jasmeer Chhatwal, Carlos Cruchaga, Neill R. Graff-Radford, Gregory S. Day, Martin Farlow, Nick Fox, Alison Goate, Jason Hassenstab, Jae-Hong Lee, Johannes Levin, Eric McDade, Hiroshi Mori, Richard Perrin, Raquel Sanchez-Valle, Peter R. Schofield, Allan Levey, Mathias Jucker, Colin L. Masters, Anne M. Fagan, Randall J. Bateman, Ralph N. Martins, Charlotte Teunissen

Summary: This study found that plasma GFAP levels increase a decade before symptom onset in AD and are associated with Aβ load, neurodegeneration, and cognitive decline.

ALZHEIMERS & DEMENTIA (2023)

Article Behavioral Sciences

The interaction between physical activity and sleep on cognitive function and brain beta-amyloid in older adults

Kelsey R. Sewell, Stephanie R. Rainey-Smith, Victor L. Villemagne, Jeremiah Peiffer, Hamid R. Sohrabi, Kevin Taddei, David Ames, Vincent Dore, Paul Maruff, Simon M. Laws, Colin L. Masters, Christopher C. Rowe, Ralph N. Martins, Kirk Erickson, Belinda M. Brown

Summary: The study suggests that physical activity may play a moderating role in the relationship between sleep, cognitive function, and brain A beta burden.

BEHAVIOURAL BRAIN RESEARCH (2023)

Review Nutrition & Dietetics

Medium-chain fatty acids for the prevention or treatment of Alzheimer's disease: a systematic review and meta-analysis

Carolina B. Castro, Cintia B. Dias, Heidi Hillebrandt, Hamid R. Sohrabi, Pratishtha Chatterjee, Tejal M. Shah, Stephanie J. Fuller, Manohar L. Garg, Ralph N. Martins

Summary: This systematic review and meta-analysis examined the effects of medium-chain fatty acid (MCFA) supplementation on circulating ketone bodies and cognition in individuals with cognitive decline and Alzheimer's disease. The results showed that MCFA supplementation increases blood ketone levels and enhances brain energy metabolism. However, the effects on cognition varied and further research is needed to determine if MCFA-mediated increase in brain energy metabolism can improve cognition.

NUTRITION REVIEWS (2023)

Article Psychology, Educational

Development of complex executive function over childhood: Longitudinal growth curve modeling of performance on the Groton Maze Learning Task

Thomas B. McGuckian, Peter H. Wilson, Rich D. Johnston, Shahin Rahimi-Golkhandan, Jan Piek, Dido Green, Jeffrey M. Rogers, Paul Maruff, Bert Steenbergen, Scott Ruddock

Summary: This longitudinal study examined the development of children's complex executive function (EF) using the Groton Maze Learning Task (GMLT). A total of 147 children (61 males, ages 5.5-11 years) were recruited from six multicultural primary schools in Melbourne and Perth, Australia. The study spanned from 2010 to 2012, with assessments on the GMLT conducted every 6 months. Growth curve models indicated a quadratic growth trajectory in each measure of error, reflecting visuospatial memory, executive control, and complex EF. The ability to apply rules for action, a key aspect of complex EF, developed rapidly during early-to-mid childhood.

CHILD DEVELOPMENT (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Validation of quantitative assessment of florbetaben PET scans as an adjunct to the visual assessment across 15 software methods

Aleksandar Jovalekic, Nuria Roe-Vellve, Norman Koglin, Mariana Lagos Quintana, Aaron Nelson, Markus Diemling, Johan Lilja, Juan Pablo Gomez-Gonzalez, Vincent Dore, Pierrick Bourgeat, Alex Whittington, Roger Gunn, Andrew W. Stephens, Santiago Bullich

Summary: The purpose of this study was to demonstrate the robustness of FBB PET quantification. The results showed that quantitative methods provided comparable results to visual assessments, indicating their potential in early detection, disease monitoring, and treatment evaluation for amyloid deposition.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Neurosciences

Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease

Pratishtha Chatterjee, Vincent Dore, Steve Pedrini, Natasha Krishnadas, Rohith Thota, Pierrick Bourgeat, Milos D. Ikonomovic, Stephanie R. Rainey-Smith, Samantha C. Burnham, Christopher Fowler, Kevin Taddei, Rachel Mulligan, David Ames, Colin L. Masters, Jurgen Fripp, Christopher C. Rowe, Ralph N. Martins, Victor L. Villemagne

Summary: Astrocyte reactivity is associated with the elevation of plasma glial fibrillary acidic protein (GFAP) and monoamine oxidase-B (MAO-B) in Alzheimer's disease. The association between plasma GFAP and regional F-18-SMBT-1 PET is dependent on brain β-amyloid (Aβ) load.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Article Critical Care Medicine

Tau, beta-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS)

Tia L. Cummins, Vincent Dore, Azadeh Feizpour, Natasha Krishnadas, Pierrick Bourgeat, Alby Elias, Fiona Lamb, Robert Williams, Malcolm Hopwood, Susan Landau, Victor L. Villemagne, Michael Weiner, Christopher C. Rowe

Summary: This case control study used positron emission tomography (PET) to investigate the risk of Alzheimer's disease (AD) in veterans with traumatic brain injury (TBI). The results showed no significant differences in beta-amyloid, tau, or brain metabolism between the TBI and control groups. These findings were validated in other independent cohorts. Therefore, it can be concluded that there is no increase in neuropathological markers of AD in veterans with a history of TBI.

JOURNAL OF NEUROTRAUMA (2023)

Article Neurosciences

Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies

Ariane Bollack, Pawel J. Markiewicz, Alle Meije Wink, Lloyd Prosser, Johan Lilja, Pierrick Bourgeat, Jonathan M. Schott, William Coath, Lyduine E. Collij, Hugh G. Pemberton, Gill Farrar, Frederik Barkhof, David M. Cash

Summary: This study evaluated the performance of four novel data-driven metrics against conventional techniques for quantifying amyloid-beta (Aβ) pathology. The results showed that the Aβ load, Aβ index, and CLNMF metrics can provide comparable performance to established quantification methods. These new metrics may offer more precise alternatives and further studies in larger cohorts should be conducted.

NEUROIMAGE (2023)

Article Neurosciences

Disease progression modelling of Alzheimer's disease using probabilistic principal components analysis

Martin Saint-Jalmes, Victor Fedyashov, Daniel Beck, Timothy Baldwin, Noel G. Faux, Pierrick Bourgeat, Jurgen Fripp, Colin L. Masters, Benjamin Goudey

Summary: The recent development of statistical models that relate changes in biomarkers with neurodegeneration and worsening condition linked to Alzheimer's Disease (AD) has potential benefits for early diagnosis and monitoring of affected individuals. One such model is the disease progression model (DPM), which describes the temporal dynamics of relevant biomarkers. However, a challenge faced by DPMs is the estimation of patient-realigning time-shifts due to the heterogeneous nature of the disease. This study proposes a probabilistic approach to estimate an individual's progression through AD using multiple biomarkers, and the results show that the estimated scores are robust and can be used as a pseudo-temporal scale for understanding the general trend in biomarker evolution.

NEUROIMAGE (2023)

Article Clinical Neurology

Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies

John J. Alam, Paul Maruff, Susan R. Doctrow, Hui-May Chu, Jennifer Conway, Stephen N. Gomperts, Charlotte Teunissen

Summary: This study evaluates the relationship between plasma tau phosphorylated at residue 181 (ptau181), a biomarker of Alzheimer disease (AD) copathology, and the treatment effects of the p38 alpha kinase inhibitor neflamapimod in patients with dementia with Lewy bodies (DLB). The results suggest that DLB patients with lower pretreatment ptau181 levels may show better treatment response to neflamapimod, with improvement in attention, cognitive assessment, and daily functioning. Plasma biomarkers of AD copathology should be considered as stratification variables in DLB clinical trials.

NEUROLOGY (2023)

Article Clinical Neurology

Validating ASHS-T1 automated entorhinal and transentorhinal cortical segmentation in Alzheimer's disease

Yi-En Quek, Pierrick Bourgeat, Yi Leng Fung, Simon J. Vogrin, Steven J. Collins, Stephen C. Bowden

Summary: This study aimed to validate the measurements of entorhinal and transentorhinal cortical volumes using the automated segmentation tool ASHS-T1. ASHS-T1 tended to underestimate the volumes compared to manual segmentation and FreeSurfer. There was low agreement between ASHS-T1 and manual segmentation volumes, and low-to-moderate agreement between ASHS-T1 and FreeSurfer volumes. ASHS-T1 showed higher consistency and agreement for the entorhinal cortex in aMCI and AD groups compared to the HC group. Despite the measurement differences, ASHS-T1 was sensitive to cortical atrophy in both early and late stages of the disease.

PSYCHIATRY RESEARCH-NEUROIMAGING (2023)

Article Geriatrics & Gerontology

Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease

Ying Xia, Paul Maruff, Vincent Dore, Pierrick Bourgeat, Simon M. Laws, Christopher Fowler, Stephanie R. Rainey-Smith, Ralph N. Martins, Victor L. Villemagne, Christopher C. Rowe, Colin L. Masters, Elizabeth J. Coulson, Jurgen Fripp

Summary: Dysfunction of the cholinergic basal forebrain system and amyloid-beta deposition are early pathological features in Alzheimer's disease. This study found that Aβ is associated with volume loss in the BF and hippocampus, and the effect varies within BF subregions. The degeneration of BF subregions during early AD also shows distinctive characteristics.

NEUROBIOLOGY OF AGING (2023)

Article Critical Care Medicine

Tau, β-Amyloid, and Glucose Metabolism following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS)

Tia L. Cummins, Vincent Dore, Azadeh Feizpour, Natasha Krishnadas, Pierrick Bourgeat, Alby Elias, Fiona Lamb, Robert Williams, Malcolm Hopwood, Susan Landau, Victor L. Villemagne, Michael C. Weiner, Christopher Rowe

Summary: This study investigates the risk of Alzheimer's disease (AD) in military veterans with traumatic brain injury (TBI) using PET imaging. The findings suggest that even with a history of TBI, there is no increase in the accumulation of neuropathological markers of AD in veterans.

JOURNAL OF NEUROTRAUMA (2023)

暂无数据